TELA Bio, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $-81.2M | $1.5M |
| FY2017 | — | $-108.2M | $11.3M |
| FY2018 | — | $-137.9M | $17.3M |
| FY2019 | $30.2M | $31.0M | $45.3M |
| FY2020 | $30.8M | $49.0M | $74.4M |
| FY2021 | $31.5M | $20.1M | $43.9M |
| FY2022 | $39.9M | $14.3M | $42.0M |
| FY2023 | $40.5M | $18.9M | $46.7M |
| FY2024 | $41.1M | $28.5M | $52.7M |
| FY2025 | $55.7M | $6.3M | $50.8M |